Otsuka Plans $2.8 Billion IPO To Feed Global Expansion
This article was originally published in The Pink Sheet Daily
Executive Summary
Still fueled by growth of the anti-psychotic Abilify, the Japanese pharma's parent company plans to list on the Tokyo Stock Exchange on December 15.